Ji. Oriordan et al., THE MANAGEMENT AND OUTCOME OF PATIENTS WITH MYASTHENIA-GRAVIS TREATEDACUTELY IN A NEUROLOGICAL INTENSIVE-CARE UNIT, European journal of neurology, 5(2), 1998, pp. 137-142
The management and clinical course of patients with myasthenia gravis
admitted to a neurological intensive therapy unit (ITU) over a 66 mont
h period were reviewed. Twenty-seven patients were admitted in myasthe
nic crisis, eight of whom had multiple admissions. One patient had a c
holinergic crisis and a further patient an acute myocardial infarction
. A specific aetiological factor precipitating myasthenic crisis was i
dentified in 19 instances: infection (8), reduction in medication (5),
menstruation (4), and steroid administration (2). Thirteen patients w
ith crisis had had a previous thymectomy, six with thymoma. Twenty-thr
ee out of 35 (66%) patients admitted in crisis required intubation; ni
ne subsequently needed a tracheostomy. Twenty-nine patients received p
lasma exchange and seven intravenous immunoglobulin. Four patients in
myasthenic crisis died in ITU [adult respiratory distress syndrome (1)
, disseminated intravascular coagulation and cytomegalovirus (CMV) pne
umonitis (1), cardiac failure (1) and multiple organ failure (1)]. App
ropriate management of myasthenia gravis requires the easy availabilit
y of specialised neuro-intensive care facilities. (C) 1998 Rapid Scien
ce Ltd.